Margarida Azevedo,  —

People with X-linked hypophosphatemia (XLH) frequently experience pain, stiffness, and fatigue, which have a significant impact on their physical functioning, mental health, and daily lives, a study reports. They also experience worsening of symptoms over time, making them concerned about the future and worried about having children with…

One-year treatment with Crysvita (burosumab) led to the normalization of phosphate levels in children with X-linked hypophosphatemia (XLH) and helped improve their growth, a small real-world study shows. The findings provide evidence of Crysvita’s effectiveness beyond clinical trials, and show that the therapy has positive effects without…